Cost-related medication nonadherence and cost-saving strategies used by elderly Medicare cancer survivors

Journal of Cancer Survivorship

Volumn 5, Issue 4, 2011, Pages 395-404

  Nekhlyudov, Larissa ^a,b   Madden, Jeanne ^a   Graves, Amy Johnson ^a   Zhang, Fang ^a   Soumerai, Stephen B ^a   Ross Degnan, Dennis ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

Author keywords

Adherence; Cancer survivorship; Cost; Elderly; Medicare

Indexed keywords

AFRICAN AMERICAN; AGED; ARTICLE; DRUG COST; ECONOMICS; ETHNOLOGY; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MEDICARE; MORTALITY; NEOPLASM; PATIENT COMPLIANCE; PROGNOSIS; PSYCHOLOGICAL ASPECT; SOCIOECONOMICS; STATISTICS; SURVIVAL RATE; SURVIVOR; UNITED STATES;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; DRUG COSTS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICAL INDIGENCY; MEDICARE; MEDICATION ADHERENCE; NEOPLASMS; PROGNOSIS; SURVIVAL RATE; SURVIVORS; UNITED STATES;

EID: 81755161512     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-011-0188-4     Document Type: Article

References (26)

1. Madden JM, Graves AJ, Zhang F, Adams AS, Briesacher BA, Ross-Degnan D, et al. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA. 2008; 299: 1922-8.
2. Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004; 27: 384-91.
3. Piette JD, Wagner TH, Potter MB, Schillinger D. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care. 2004; 42: 102-9.
4. Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001; 285: 421-9.
5. Brown ML, Riley GF, Schussler N, Elzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002; 40(Supplemental IV): 104-17.
6. Chang S, Long SR, Kutikova L, Bowman L, Finley D, Crown WH, et al. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol. 2004; 22: 3524-30.
7. Meropol NJ, Schulman KA. Cost of cancer care: issues and implications. J Clin Oncol. 2007; 25: 180-6.
8. Langa KM, Fendrick AM, Chernew ME, Kabeto M, Paisley KL, Hayman JA. Out-of-pocket health-care expenditures among older Americans with cancer. Value Health. 2004; 7: 186-94.
9. The USA Today/Kaiser Family Foundation/Harvard School of Public Health. National survey of households affected by cancer. Menlo Park: The Henry J. Kaiser Family Foundation; 2006.
10. Himmelstein DU, Warren E, Thorne D, Woolhandler S. Illness and injury as contributors to bankruptcy. Health Affairs 2005; Suppl W5: 63-73.
11. Institute of Medicine and National Research Council of the National Academies. From cancer patient to cancer survivor: lost in transition. Washington: The National Academies; 2006.
12. Weaver KE, Rowland JH, Bellizzi KM, Aziz NM. Forgoing medical care because of cost. Assessing disparities in healthcare access among cancer survivors living in the United States. Cancer. 2010; 116: 3493-504.
13. Pierre-Jacques M, Safran DG, Zhang F, Ross-Degnan D, Adams AS, Gurwitz J, et al. Reliability of new measures of cost related medication nonadherence. Med Care. 2008; 46: 444-8.
14. Bambauer KZ, Safran DG, Ross-Degnan D, Zhang F, Adams AS, Gurwitz J, et al. Depression and cost-related medication nonadherence in Medicare beneficiaries. Arch Gen Psych. 2007; 64: 602-8.
15. Soumerai SB, Pierre-Jacques M, Ross-Degnan D, Adams AS, Gurwitz JH. Cost-related medication non-adherence among the elderly and the disabled: a national survey one year before the Medicare drug benefit. Arch Intern Med. 2006; 166: 1829-35.
16. Tjia J, Briesacher BA, Soumerai SB, Pierre-Jacques M, Zhang F, Ross-Degnan D, et al. Medicare beneficiaries and free prescription drug samples: a national survey. J Gen Intern Med. 2008; 23: 709-14.
17. Yabroff KR, Warren JL, Banthin J, Schrag D, Mariotto A, Lawrence W, et al. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source? Med Care. 2009; 47(Suppl): S64-9.
18. Mohile SG, Xian Y, Dale W, Fisher SG, Rodin M, Morrow GR, et al. Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries. J Natl Cancer Inst. 2009; 101: 1206-15.
19. Lash TL, Fox MP, Westrup JL, Fink AK, Silliman RA. Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat. 2006; 99: 215-20.
20. Owusu C, Buist DSM, Field TS, Lash TL, Thwin SS, Geiger AM, et al. Predictors of tamoxifen discontinuation among older women with estrogen receptor-breast cancer. J Clin Oncol. 2008; 26: 549-55.
21. Partridge AH, Wang PS, Winer EP, Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2003; 21: 602-6.
22. Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009; 59: 56-66.
23. Chlebowski RT, Geller ML. Adherence to endocrine therapy for breast cancer. Oncology. 2006; 71: 1-9.
24. Pezzin LE, O'Niel MB, Nattinger AB. The economic consequences of breast cancer adjuvant hormonal treatments. J Gen Intern Med. 2009; 24 Suppl 2: S446-50.
25. Kim P. Cost of cancer care: the patient perspective. J Clin Oncol. 2007; 25: 228-32.
26. Krouse RS, Herrinton LJ, Grant M, Wendel CS, Green SB, Mohler MJ, et al. Health-related quality of life among long-term rectal cancer survivors with an ostomy: manifestations by sex. J Clin Oncol. 2009; 27: 4664-70.